{"data":[{"accessionNo":"0002100119-26-001561","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals Inc","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":3957862,"percentOfClass":4.87,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0002100119-26-001370","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals Inc","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":3898446,"percentOfClass":5.05,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0000921895-26-001390","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":7868419,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0000921895-26-001390","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":7868419,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0000921895-26-001390","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":7868419,"percentOfClass":9.99,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0000921895-26-001390","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":7439174,"percentOfClass":9.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0000921895-26-001390","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":5382084,"percentOfClass":6.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0000921895-26-001390","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":5382084,"percentOfClass":6.8,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0000921895-26-001390","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":2057090,"percentOfClass":2.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0000921895-26-001390","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":2057090,"percentOfClass":2.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0000921895-26-001390","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":301588,"percentOfClass":0.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0000921895-26-001390","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-03-31","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":301588,"percentOfClass":0.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0002012383-26-001685","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":4380857,"percentOfClass":5.8,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0000102909-26-001125","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals Inc","ticker":"ELDN","cusip":"28617K101","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001346824-26-000041","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001346824-26-000041","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001346824-26-000041","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001346824-26-000041","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-12-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001104659-26-015219","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Coastlands Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3937826,"percentOfClass":4.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001104659-26-015219","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Coastlands Capital Partners LP","reportingCik":null,"personType":"PN","sharesOwned":3937826,"percentOfClass":4.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001104659-26-015219","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Coastlands Capital GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3937826,"percentOfClass":4.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001104659-26-015219","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Coastlands Capital LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":3937826,"percentOfClass":4.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001104659-26-015219","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Matthew D. Perry","reportingCik":null,"personType":"HC,IN","sharesOwned":3908467,"percentOfClass":4.99,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0002012383-26-000664","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":3625824,"percentOfClass":4.6,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001104659-25-115374","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-19","reportingPerson":"Matthew D. Perry","reportingCik":null,"personType":"HC,IN","sharesOwned":4762691,"percentOfClass":5.98,"filedAt":"2025-11-24","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001104659-25-115374","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-19","reportingPerson":"Coastlands Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":4203764,"percentOfClass":5.28,"filedAt":"2025-11-24","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001104659-25-115374","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-19","reportingPerson":"Coastlands Capital Partners LP","reportingCik":null,"personType":"PN","sharesOwned":4203764,"percentOfClass":5.28,"filedAt":"2025-11-24","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001104659-25-115374","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-19","reportingPerson":"Coastlands Capital GP LLC","reportingCik":null,"personType":"OO","sharesOwned":4203764,"percentOfClass":5.28,"filedAt":"2025-11-24","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"},{"accessionNo":"0001104659-25-115374","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001404281","issuerName":"Eledon Pharmaceuticals, Inc.","ticker":"ELDN","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-11-19","reportingPerson":"Coastlands Capital LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":4203764,"percentOfClass":5.28,"filedAt":"2025-11-24","canonicalUrl":"https://xoomar.com/markets/stocks/eldn"}],"updatedAt":"2026-11-04T03:21:57.056Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/eldn","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}